Bronstein, Gewirtz & Grossman notifies investors that a class action lawsuit has been filed against Viatris (VTRS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Viatris securities between August 8, 2024 and February 26 both dates inclusive. The Complaint alleges that Defendants provided investors with material information concerning the failed inspection of Viatris’ Indore, India facility. Specifically, the Complaint alleges that Defendants’ statements misrepresented the FDA’s issuance of a warning letter and its impact on Viatris’ operations and that Defendants routinely referred to the impact of the warning letter as a mere “minor headwind” for the Company. A class action lawsuit has already been filed. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTRS: